EUVIMEDEUVIMED entdecken
Open Access

De novo and inherited variants in DDX39B cause a novel neurodevelopmental syndrome

Kevin T A Booth, Sharayu V Jangam, Martin M C Chui, Kayla Treat, Lorenzo Graziani, Alessia Soldano, Yao Ruan, Jeffrey Wan-Hei Hui, Kerry White, Celanie K Christensen, Ty Lynnes, Shinya Yamamoto iD und 17 weitere

Brain · 2025

DOI: 10.1093/brain/awaf035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Kevin T A Booth und 28 weiteren Autor:innen. Beteiligte Einrichtung: Indiana University School of Medicine, Department of Medical and Molecular Genetics, Undiagnosed Rare Disease Clinic, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: DEAD-box RNA Helicases, Neurodevelopmental Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Health, Society for the Relief of Disabled Children, Health Innovation Challenge Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DDX39B is a conserved member of the DEAD-box family of ATP-dependent RNA helicases, critical in mRNA metabolism across eukaryotes. DDX39B is also a core component of the TRanscription-EXport (TREX) super protein complex, and recent studies have highlighted the important role of its subunits in neurodevelopmental disorders. Here, we describe six individuals from five families, four harbouring de novo missense variants in DDX39B and one with an inherited splicing variant, presenting with variable developmental delay, congenital hypotonia, epilepsy, short stature, skeletal abnormalities, dysmorphic features and microcephaly in three patients. 3D molecular modelling predicts these variants would alter protein structure. In vitro studies using overexpression of HA-tagged human DDX39B protein in 293FT cells revealed variants p.(Gly92Asp) and c.433-1G>T impaired interaction with DDX39B and other TREX complex members, while variants p.(Gly37Cys), p.(Ser44Arg) and p.(Arg123Gln) did not affect TREX complex assembly. Blood transcriptomics studies demonstrated significantly elevated aberrant splicing events in individuals carrying the p.(Gly37Cys), p.(Arg123Gln) or c.433-1G>T variant, compared to controls, suggesting a mRNA signature of disrupted mRNA splicing and export. To understand variant effects in vivo, we generated Drosophila transgenic DDX39B-reference and variant flies. Human reference DDX39B, when overexpressed ubiquitously, led to lethality, but the patient variants did not, suggesting that the mutants are loss-of-function alleles. Zebrafish anti-sense morpholino knockdown of DDX39B led to reduced head size and body length consistent with the patient phenotypes, and these effects were mitigated by synthesized mRNA, indicating a loss-of-function effect of DDX39B. Collectively, our human genetic data, coupled with in silico, in vitro and in vivo data, support DDX39B as a novel candidate gene in a potential group of disorders called TREX-complex-related neurodevelopmental syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DEAD-box RNA HelicasesNeurodevelopmental DisordersHumansMaleFemaleAnimalsChildChild, PreschoolPedigreeMutation, MissenseZebrafishDevelopmental DisabilitiesHEK293 CellsInfantAdolescent

Stichwörter der Autor:innen

DDX39BTRanscription-EXport (TREX) super protein complexneurodevelopmental disordertranscriptomicszebrafish and Drosophila functional studies

Substanzen

DEAD-box RNA HelicasesDDX39B protein, human

Autor:innen und Institutionen

  • Indiana University School of Medicine, Department of Medical and Molecular Genetics, Undiagnosed Rare Disease Clinic, Indianapolis, IN 46202, USA.
  • Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, IN 46202, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Center for Precision Medicine Modeling, Baylor College of Medicine, Houston, TX 77030, USA.
  • Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX 77030, USA.

ORCID-Profile: Shinya Yamamoto

Förderung

  • Department of Health
  • Society for the Relief of Disabled Children
  • Health Innovation Challenge Fund
  • ODCDC CDC HHS
  • Wellcome Sanger Institute
  • Hong Kong Food and Health Bureau
  • Health and Medical Research Fund (HMRF)
  • Wellcome Trust

Zitieren

APA

Booth, K. T. A., Jangam, S. V., Chui, M. M. C., Treat, K., Graziani, L., Soldano, A., Ruan, Y., Wan-Hei Hui, J., White, K., Christensen, C. K., Lynnes, T., Yamamoto, S., Kanca, O., Tsang, M. H. Y., Lynch, S. A., Mullegama, S. V., Baptista, J., Iancu, D., Joss, S. K., …, & Vetrini, F. (2025). De novo and inherited variants in DDX39B cause a novel neurodevelopmental syndrome. Brain. https://doi.org/10.1093/brain/awaf035

Vancouver

Booth KTA, Jangam SV, Chui MMC, Treat K, Graziani L, Soldano A, et al. De novo and inherited variants in DDX39B cause a novel neurodevelopmental syndrome. Brain. 2025. doi:10.1093/brain/awaf035

BibTeX
@article{Booth2025,
  author = {Booth, Kevin T A and Jangam, Sharayu V and Chui, Martin M C and Treat, Kayla and Graziani, Lorenzo and Soldano, Alessia and Ruan, Yao and Wan-Hei Hui, Jeffrey and White, Kerry and Christensen, Celanie K and Lynnes, Ty and Yamamoto, Shinya and Kanca, Oguz and Tsang, Mandy H Y and Lynch, Sally A and Mullegama, Sureni V and Baptista, Julia and Iancu, Daniela and Joss, Shelagh K and Wong, Sandra Y Y and Mak, Christopher C Y and Kwong, Anna K Y and Bellen, Hugo J and Conboy, Erin and Sanges, Remo and Leung, Anskar Yu-Hung and Wangler, Michael F and Chung, Brian H Y and Vetrini, Francesco},
  title = {De novo and inherited variants in DDX39B cause a novel neurodevelopmental syndrome},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awaf035}
}
Kostenlos starten →